What is the current annual SG&A of ABBV?

As of today, ABBV annual SG&A is $0.00

What is 1-year change in ABBV annual SG&A?

ABBV annual SG&A is down -100.00% year-over-year

What is 3-year change in ABBV annual SG&A?

ABBV annual SG&A is down -100.00% over the past 3 years

How far is ABBV annual SG&A from its all-time high?

ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022

How does ABBV annual SG&A rank versus sector peers?

ABBV annual SG&A is higher than 70.87% of companies in Healthcare sector

When is ABBV next annual earnings release?

The next annual earnings release for ABBV is on February 3, 2027

What is the current quarterly SG&A of ABBV?

As of today, ABBV quarterly SG&A is $4.09B

What is ABBV quarterly SG&A most recent change?

ABBV quarterly SG&A was up +12.53% on September 30, 2026

What is 1-year change in ABBV quarterly SG&A?

ABBV quarterly SG&A is up +14.51% year-over-year

How far is ABBV quarterly SG&A from its all-time high?

ABBV quarterly SG&A is currently -24.48% below its historical high of $5.41B set on June 30, 2022

How does ABBV quarterly SG&A rank versus sector peers?

ABBV quarterly SG&A is higher than 99.62% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

What is the current TTM SG&A of ABBV?

As of today, ABBV TTM SG&A is -$66.89B

What is ABBV TTM SG&A most recent change?

ABBV TTM SG&A was down -3.01% on September 30, 2026

What is 1-year change in ABBV TTM SG&A?

ABBV TTM SG&A is down -578.80% year-over-year

How does ABBV TTM SG&A rank versus sector peers?

ABBV TTM SG&A is higher than 0.18% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

AbbVie Inc. (ABBV) SG&A History & Chart Since 2009

Annual SG&A

$0.00$14.75B-100.00%

December 31, 2025

Summary

Current Value: As of today, ABBV annual SG&A is $0.00, down -100.00% on December 31, 2025
Historical Performance: ABBV annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
All-Time High Comparison: ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022
Sector Comparison: ABBV annual SG&A is higher than 70.87% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 26	$4.09B	+14.5%	+21.2%	+32.6%	+60.9%
TTM SG&A	Sep 30, 26	-$66.89B	-578.8%	-610.8%	-642.9%	-1505.3%
Price	Nov 13, 26	$295.03	+27.0%	+112.8%	+152.2%	–
Annual Operating Expenses	Dec 31, 25	$29.98B	+31.1%	+57.7%	+86.7%	+387.5%
Annual Operating Profit	Dec 31, 25	$21.21B	+27.6%	-6.1%	+35.7%	+311.4%
Annual D&A	Dec 31, 25	$8.14B	-3.0%	-3.9%	+25.8%	+587.2%
Annual Revenue	Dec 31, 25	$61.16B	+8.6%	+5.3%	+33.5%	+291.1%

SG&A Highs

ABBV Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$15.26B	N/A	-100.0%
5Y	$15.26B	Dec 31, 22	-100.0%
All	$15.26B	Dec 31, 22	-100.0%

SG&A Lows

ABBV Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$0.00	Dec 31, 25	N/A
5Y	$0.00	Dec 31, 25	N/A
All	$0.00	Dec 31, 25	N/A

SG&A History

Year	Value	Change
2025	$0.00	-100.0%
2024	$14.75B	+14.6%
2023	$12.87B	-15.6%
2022	$15.26B	+23.6%
2021	$12.35B	+9.3%
2020	$11.30B	+62.8%
2019	$6.94B	-6.2%
2018	$7.40B	+17.5%
2017	$6.30B	+7.5%

Year	Value	Change
2016	$5.86B	-8.3%
2015	$6.39B	-17.3%
2014	$7.72B	+44.3%
2013	$5.35B	+7.3%
2012	$4.99B	-15.4%
2011	$5.89B	+54.3%
2010	$3.82B	+14.1%
2009	$3.35B	-

FAQ

What is the current annual SG&A of ABBV?: As of today, ABBV annual SG&A is $0.00
What is 1-year change in ABBV annual SG&A?: ABBV annual SG&A is down -100.00% year-over-year
What is 3-year change in ABBV annual SG&A?: ABBV annual SG&A is down -100.00% over the past 3 years
How far is ABBV annual SG&A from its all-time high?: ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022
How does ABBV annual SG&A rank versus sector peers?: ABBV annual SG&A is higher than 70.87% of companies in Healthcare sector
When is ABBV next annual earnings release?: The next annual earnings release for ABBV is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$4.09B$455.00M+12.53%

September 30, 2026

Summary

Current Value: As of today, ABBV quarterly SG&A is $4.09B, up +12.53% on September 30, 2026
Historical Performance: ABBV quarterly SG&A is up +14.51% year-over-year, up +21.20% over the past 3 years
All-Time High Comparison: ABBV quarterly SG&A is currently -24.48% below its historical high of $5.41B set on June 30, 2022
3-Year Low Comparison: ABBV quarterly SG&A is +28.00% above its 3-year low of $3.19B reached on December 31, 2023
Sector Comparison: ABBV quarterly SG&A is higher than 99.62% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Sep 30, 26	$4.09B	+12.5%	+14.5%	+21.2%	+32.6%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
TTM SG&A	Sep 30, 26	-$66.89B	-555.8%	-578.8%	-610.8%	-642.9%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
Quarterly Operating Expenses	Sep 30, 26	$8.31B	+39.0%	+41.9%	+64.6%	+79.8%
Quarterly Operating Profit	Sep 30, 26	$6.48B	-3.5%	+41.6%	+42.7%	+19.9%
Quarterly D&A	Sep 30, 26	$1.86B	-1.2%	-9.8%	-16.7%	-12.5%
Quarterly Revenue	Sep 30, 26	$17.40B	+2.4%	+10.3%	+25.0%	+21.4%

Quarterly SG&A Highs

ABBV Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$4.09B	Sep 30, 26	at high
3Y	$4.21B	Sep 30, 24	-2.8%
5Y	$5.41B	Jun 30, 22	-24.5%
All	$5.41B	Jun 30, 22	-24.5%

Quarterly SG&A Lows

ABBV Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$3.57B	N/A	+14.5%
3Y	$3.19B	Dec 31, 23	+28.0%
5Y	$3.04B	Mar 31, 23	+34.5%
All	$1.04B	Jun 30, 11	+292.6%

Quarterly SG&A History

Month	Value	Change
Sep 2026	$4.09B	+12.5%
Jun 2026	$3.63B	+1.5%
Mar 2026	$3.58B	-8.1%
Dec 2025	$3.90B	+9.1%
Sep 2025	$3.57B	+9.7%
Jun 2025	$3.25B	-1.2%
Mar 2025	$3.29B	-14.6%
Dec 2024	$3.86B	-8.3%
Sep 2024	$4.21B	+24.5%
Jun 2024	$3.38B	+1.9%
Mar 2024	$3.32B	+3.8%
Dec 2023	$3.19B	-5.3%
Sep 2023	$3.37B	+3.2%
Jun 2023	$3.27B	+7.5%
Mar 2023	$3.04B	-11.1%
Dec 2022	$3.42B	+3.4%
Sep 2022	$3.30B	-39.0%
Jun 2022	$5.41B	+73.1%
Mar 2022	$3.13B	-4.1%
Dec 2021	$3.26B	+5.7%
Sep 2021	$3.08B	-2.6%
Jun 2021	$3.16B	+11.3%
Mar 2021	$2.84B	-12.0%
Dec 2020	$3.23B	+13.5%
Sep 2020	$2.85B	-19.3%
Jun 2020	$3.53B	+108.1%
Mar 2020	$1.70B	-13.1%
Dec 2019	$1.95B	+17.7%
Sep 2019	$1.66B	+0.2%
Jun 2019	$1.65B	-1.5%
Mar 2019	$1.68B	-12.9%
Dec 2018	$1.93B	+0.5%

Month	Value	Change
Sep 2018	$1.92B	+9.0%
Jun 2018	$1.76B	-1.7%
Mar 2018	$1.79B	-8.4%
Dec 2017	$1.96B	+34.2%
Sep 2017	$1.46B	-3.1%
Jun 2017	$1.50B	+9.9%
Mar 2017	$1.37B	-17.2%
Dec 2016	$1.65B	+19.7%
Sep 2016	$1.38B	-5.8%
Jun 2016	$1.47B	+8.2%
Mar 2016	$1.36B	-22.0%
Dec 2015	$1.74B	+17.8%
Sep 2015	$1.47B	-13.4%
Jun 2015	$1.70B	+15.6%
Mar 2015	$1.47B	-55.9%
Dec 2014	$3.34B	+109.5%
Sep 2014	$1.60B	+10.2%
Jun 2014	$1.45B	+8.1%
Mar 2014	$1.34B	-7.5%
Dec 2013	$1.45B	+14.8%
Sep 2013	$1.26B	-10.3%
Jun 2013	$1.41B	+13.7%
Mar 2013	$1.24B	-12.3%
Dec 2012	$1.41B	+29.9%
Sep 2012	$1.09B	-12.9%
Jun 2012	$1.25B	-0.1%
Mar 2012	$1.25B	+10.0%
Dec 2011	$1.13B	-55.4%
Sep 2011	$2.54B	+144.1%
Jun 2011	$1.04B	-11.6%
Mar 2011	$1.18B	-

FAQ

What is the current quarterly SG&A of ABBV?: As of today, ABBV quarterly SG&A is $4.09B
What is ABBV quarterly SG&A most recent change?: ABBV quarterly SG&A was up +12.53% on September 30, 2026
What is 1-year change in ABBV quarterly SG&A?: ABBV quarterly SG&A is up +14.51% year-over-year
How far is ABBV quarterly SG&A from its all-time high?: ABBV quarterly SG&A is currently -24.48% below its historical high of $5.41B set on June 30, 2022
How does ABBV quarterly SG&A rank versus sector peers?: ABBV quarterly SG&A is higher than 99.62% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

-$66.89B$1.96B-3.01%

September 30, 2026

Summary

Current Value: As of today, ABBV TTM SG&A is -$66.89B, down -3.01% on September 30, 2026
Historical Performance: ABBV TTM SG&A is down -578.80% year-over-year, down -610.75% over the past 3 years
All-Time High Comparison: ABBV TTM SG&A is currently -390.56% below its historical high of $23.02B set on an earlier date
3-Year Low Comparison: ABBV TTM SG&A is at its 3-year low
Sector Comparison: ABBV TTM SG&A is higher than 0.18% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Sep 30, 26	-$66.89B	-555.8%	-578.8%	-610.8%	-642.9%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 26	$4.09B	+12.5%	+14.5%	+21.2%	+32.6%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
TTM Operating Profit	Sep 30, 26	$23.91B	+8.7%	+25.5%	+13.0%	+26.5%
TTM D&A	Sep 30, 26	$7.67B	-2.6%	-7.1%	-12.7%	-10.9%
TTM Revenue	Sep 30, 26	$66.01B	+2.5%	+10.7%	+19.7%	+19.7%

TTM SG&A Highs

ABBV TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	-$43.16B	N/A	-55.0%
3Y	$9.90B	N/A	-775.7%
5Y	$18.36B	N/A	-464.4%
All	$23.02B	N/A	-390.6%

TTM SG&A Lows

ABBV TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	-$66.89B	N/A	at low
3Y	-$66.89B	N/A	at low
5Y	-$66.89B	N/A	at low
All	-$66.89B	N/A	at low

TTM SG&A History

Month	Value	Change
Sep 2026	$15.19B	+3.5%
Jun 2026	$14.67B	+2.7%
Mar 2026	$14.30B	+2.0%
Dec 2025	$14.01B	+0.3%
Sep 2025	$13.97B	-4.4%
Jun 2025	$14.61B	-0.8%
Mar 2025	$14.73B	-0.1%
Dec 2024	$14.75B	+4.7%
Sep 2024	$14.09B	+6.3%
Jun 2024	$13.26B	+0.8%
Mar 2024	$13.15B	+2.1%
Dec 2023	$12.87B	-1.7%
Sep 2023	$13.10B	+0.5%
Jun 2023	$13.03B	-14.1%
Mar 2023	$15.17B	-0.6%
Dec 2022	$15.26B	+1.0%
Sep 2022	$15.10B	+1.5%
Jun 2022	$14.88B	+17.8%
Mar 2022	$12.63B	+2.3%
Dec 2021	$12.35B	+0.2%
Sep 2021	$12.32B	+2.0%
Jun 2021	$12.08B	-2.9%
Mar 2021	$12.45B	+10.2%
Dec 2020	$11.30B	+12.8%
Sep 2020	$10.02B	+13.5%
Jun 2020	$8.83B	+26.9%
Mar 2020	$6.96B	+0.2%
Dec 2019	$6.94B	+0.3%
Sep 2019	$6.92B	-3.6%
Jun 2019	$7.18B	-1.5%
Mar 2019	$7.29B	-1.5%
Dec 2018	$7.40B	-0.4%

Month	Value	Change
Sep 2018	$7.43B	+6.6%
Jun 2018	$6.96B	+3.8%
Mar 2018	$6.71B	+6.7%
Dec 2017	$6.29B	+5.1%
Sep 2017	$5.98B	+1.3%
Jun 2017	$5.91B	+0.6%
Mar 2017	$5.87B	+0.2%
Dec 2016	$5.86B	-1.4%
Sep 2016	$5.94B	-1.5%
Jun 2016	$6.03B	-3.8%
Mar 2016	$6.27B	-1.8%
Dec 2015	$6.39B	-20.1%
Sep 2015	$7.99B	-1.5%
Jun 2015	$8.11B	+3.2%
Mar 2015	$7.86B	+1.7%
Dec 2014	$7.72B	+32.5%
Sep 2014	$5.83B	+6.1%
Jun 2014	$5.50B	+0.8%
Mar 2014	$5.46B	+1.9%
Dec 2013	$5.35B	+0.7%
Sep 2013	$5.31B	+3.4%
Jun 2013	$5.14B	+3.2%
Mar 2013	$4.98B	-0.2%
Dec 2012	$4.99B	+5.9%
Sep 2012	$4.71B	-23.6%
Jun 2012	$6.17B	+3.4%
Mar 2012	$5.96B	+1.2%
Dec 2011	$5.89B	+23.8%
Sep 2011	$4.76B	+114.5%
Jun 2011	$2.22B	+88.4%
Mar 2011	$1.18B	-

FAQ

What is the current TTM SG&A of ABBV?: As of today, ABBV TTM SG&A is -$66.89B
What is ABBV TTM SG&A most recent change?: ABBV TTM SG&A was down -3.01% on September 30, 2026
What is 1-year change in ABBV TTM SG&A?: ABBV TTM SG&A is down -578.80% year-over-year
How does ABBV TTM SG&A rank versus sector peers?: ABBV TTM SG&A is higher than 0.18% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv